The long-chain polyunsaturated fatty acids (PUFSs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have a proven record to benefit heart health, according to long-time omega-3 researcher Bruce J. Holub, Ph.D., university professor emeritus, deptartment of human health & nutritional sciences, University of Guelph. In this podcast, Holub and Sandy Almendarez, editor in chief, INSIDER discuss specific studies on EPA and DHA, and the role they play in cardiovascular health. They cover:
- People with heart failure who supplement with 1 g/d of EPA/DHA had a reduction in total mortality by 10 percent, which is the same rate as some prescription drugs
- A modest dose of EPA/DHA (700 mg/d) lowered systolic blood pressure by about 5 percent, which can result in an 18-percent reduction in coronary heart disease risk
- A 1 g/d dose of EPA/DHA reduced circulating triglycerides by 8 percent in a two-week period whether patients were on a prescription statin or not.
Holub will be speaking at the Supplyside West Workshop, “Nutrition for Heart Health” on Friday, September 29 at 8:30 to 11:30 a.m. This session is underwritten by Nicolas Hall and Companies, Japan Bio Sciences Lab and Natec. Visit supplysideshow.com for more information and to get registered.